Results 151 to 160 of about 1,716,661 (233)

Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation. [PDF]

MedComm (2020)
Bai Z, Yi M, Hu S, Xue D, Wei L, Zhang L, Dai Z.   +6 more
europepmc   +1 more source

The carbon footprint of Chimeric Antigen Receptor-T cell manufacturing processes. [PDF]

Int J Pharm X
van der Bijl WE, Gareb B, Klomberg KM, Bremer E, van Meerten T, Oude Munnink TH, Dekkers BGJ.   +6 more
europepmc   +1 more source

Could chimeric antigen receptor-T cell treatment of atherosclerosis in mice translate to a human therapy? [PDF]

Ann Transl Med
Gieseg S, Hock B, Ogugofor M, McCormick S.   +3 more
europepmc   +1 more source

Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma. [PDF]

Cancer Res
Clubb JD, Shih RM, Gao TA, Shafer A, Vajragiri S, Lam K, Talluri S, Bouren A, Brown CE, Ruivo P, Prins RM, Wu HC, Chen YY.   +12 more
europepmc   +1 more source

Editorial: Chimeric antigen receptor T cell therapies and bispecific antibodies in hematologic malignancies. [PDF]

Front Oncol
Zhu Y.
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries. [PDF]

Eur Heart J
Zaghlol R, Deych E, Ladin DA, Russler-Germain DA, Schiffer W, Baral N, Waken RJ, Ky B, Joynt Maddox KE, Mitchell JD.   +9 more
europepmc   +1 more source

Cord Blood-Derived Fibroblast Activation Protein-Targeted Chimeric Antigen Receptor Natural Killer Cells Persist in Vivo. [PDF]

Cancer Sci
Hiroshima T, Kimura T, Maekawa M, Noguchi M, Matsui T, Ikeda S, Suga M, Nagata H, Kimura K, Fukui E, Kanou T, Ose N, Morii E, Shintani Y, Hosen N.   +14 more
europepmc   +1 more source

NOT-gated chimeric antigen receptor circuits in T and NK cells. [PDF]

Cell Syst
Lee S, Chen J, Siddiqui MY, Choi J, Huang J, Lee D, Lee CT, Almudhfar N, Tian M, Banicki A, Ayala MG, Gordley R, Lu TK, Frankel NW, Wong WW.   +14 more
europepmc   +1 more source

Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T-Cell Therapy. [PDF]

J Cardiovasc Dev Dis
Naser A, Morgan AA, Zhang L.
europepmc   +1 more source

Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases. [PDF]

Front Immunol
Zhou S, Li Y, Zhao J, Zhan W, Zhou C, Zou Y, Li X, Cui J, Wu J, Xia J.   +9 more
europepmc   +1 more source